NT PHARMA-NEW Stock Forum

The company's poor financial performance and declining revenue may be causing its low P/S ratio and share price. The trend is expected to continue, affecting the share price further. Its revenue growth is lagging behind the industry, contributing to the low P/S ratio. The share price may continue to suffer unless conditions improve.

The company's receding revenue and market's expectation of limited future growth contributes to its low P/S ratio. The continuation of medium-term revenue trends understates a likely reversal in fortune. Multiple risks, including one major warning sign, are present.

hi